insitro
Making Medicines Differently
South San Francisco, United States · Founded 2018 · $643.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 201–500
- Founded
- 2018
- Business Model
- B2B
- Website
- insitro.com
- Total Funding
- $643.0M
- Last Round
- $400.0M Series CMar 2021
- Rounds
- 3
About
insitro is a machine learning-driven drug discovery company that integrates in vitro cellular data from automated labs with human clinical data to identify novel disease targets and therapeutics. The company builds a wholly-owned and partnered pipeline across metabolism, oncology, and neuroscience, with programs including POSH (CRISPR screening + Vision Transformers) and TherML therapeutic design.
Summary
insitro is an Artificial Intelligence company based in South San Francisco, United States, founded in 2018. It has raised $643.0M in total across 3 rounds, most recently a $400.0M Series C round in Mar 2021. Investors include Andreessen Horowitz, Canada Pension Plan Investment Board and T. Rowe Price.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
.png)
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company